
Week 6: Regulatory Shifts, Tariff Action & Industry Feedback
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
My Profile
Policy
On behalf of our members, AdvaMed® works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
AdvaMed calls for federal privacy laws that reflect how medical devices use patient data differently from consumer health tools.
AdvaMed urges DOJ to remove outdated rules that block medtech innovation and limit access to lifesaving technology.
White House tariff actions, DOJ and CMS RFIs, and USTR investigations headline Week 5—member feedback needed this month.
Scott Whitaker’s Senate testimony, drug pricing EO, and updates on key RFIs drive this week’s momentum for MedTech advocacy.
The U.S. Supreme Court is reviewing Braidwood Management v. Becerra, a high-stakes case challenging the authority of the U.S. Preventive Services Task Force (USPSTF) under the Affordable Care Act. At…
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
AdvaMed calls for federal privacy laws that reflect how medical devices use patient data differently from consumer health tools.
AdvaMed urges DOJ to remove outdated rules that block medtech innovation and limit access to lifesaving technology.
White House tariff actions, DOJ and CMS RFIs, and USTR investigations headline Week 5—member feedback needed this month.
AdvaMed® members have access to our full library of industry resources.
Levallois-Perret, France – May 22, 2025 — Cardiawave SA, medtech company specialized in valvular heart disease, presented today at the EuroPCR Congress the 12-month results from its “Valvosoft® FIM Study”…
AdvaMed President and CEO Scott Whitaker testified before the U.S. Senate Finance Committee, bringing attention to the pressing issue of how tariffs could impact the medtech industry and, most importantly,…
WASHINGTON—AdvaMed, the Medtech Association, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
WASHINGTON—AdvaMed, the Medtech Association, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
Washington, D.C.–AdvaMed President and CEO Scott Whitaker released the following statement upon re-introduction of bipartisan legislation aimed at accelerating Medicare coverage for breakthrough medtech and diagnostics. The Ensuring Patient Access…
At AdvaMed, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame…
Bern/Washington – Swiss Medtech, the leading trade association for medical technology companies in Switzerland, and AdvaMed, the U.S. Medtech Association and the world’s largest organization representing medtech innovators, are jointly…
WASHINGTON – Today, President and CEO Scott Whitaker of AdvaMed, the Medtech Association, testified before the U.S. Senate Committee on Finance in its hearing focused on the impact of tariffs…
Join thousands of industry leaders October 5-8, 2025, in San Diego, California for direct access to hundreds of hours of timely medtech education, networking with industry leaders and CEOs, and…
AdvaMed President and CEO Scott Whitaker describes the importance of engaging patients in every stage of medtech innovation.
We are pleased to provide AdvaMed® members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.